Thermo Fisher Scientific
TMO
1,559 hedge funds and large institutions have $105B invested in Thermo Fisher Scientific in 2019 Q2 according to their latest regulatory filings, with 124 funds opening new positions, 575 increasing their positions, 622 reducing their positions, and 66 closing their positions.
88% more first-time investments, than exits
New positions opened: 124 | Existing positions closed: 66
20% more call options, than puts
Call options by funds: $336M | Put options by funds: $280M
8% more capital invested
Capital invested by funds: $97.7B → $105B (+$7.44B)
2% more funds holding
Funds holding: 1,523 → 1,559 (+36)
0.13% more ownership
Funds ownership: 89.55% → 89.67% (+0.13%)
1% less funds holding in top 10
Funds holding in top 10: 149 → 148 (-1)
8% less repeat investments, than reductions
Existing positions increased: 575 | Existing positions reduced: 622
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$562M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$526M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$241M |
| 4 |
Jennison Associates
New York
|
+$217M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$191M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$497M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$314M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$172M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$133M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$127M |
TMO Hedge Fund Activity: Q2 2019 in Review
1,559 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2019, worth a combined $105B — up 7.6% from $97.7B a quarter earlier.
Buyers outnumbered sellers: 124 funds opened new TMO positions and 66 closed out — a net gain of 58 holders — while 575 added to existing stakes and 622 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $562M. The largest seller was Capital Research Global Investors, cutting an estimated $497M.
- 1,559 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2019, up from 1,523 in Q1 2019.
- Funds reported $105B of Thermo Fisher Scientific stock for Q2 2019, up 7.6% quarter-over-quarter.
- 124 funds opened new Thermo Fisher Scientific positions in Q2 2019 and 66 closed out, a net change of +58 holders.
- The largest Thermo Fisher Scientific buyer in Q2 2019 was JP Morgan Chase, an estimated $562M added.
- The largest Thermo Fisher Scientific seller in Q2 2019 was Capital Research Global Investors, an estimated $497M sold.
Based on aggregated 13F filings for Q2 2019.